Glutamate Receptors within the Mesolimbic Dopamine System Mediate Alcohol Relapse Behavior

• Published in: The Journal of neuroscience Vol. 35; no. 47; pp. 15523 - 15538
• Main Authors: Eisenhardt, Manuela, Leixner, Sarah, Luján, Rafael, Spanagel, Rainer, Bilbao, Ainhoa
• Format: Journal Article
• Language: English
• Published: United States Society for Neuroscience 25-11-2015
• Subjects: Alcoholism - metabolism; Animals; Behavior, Addictive - metabolism; Dopamine - physiology; Dopamine Plasma Membrane Transport Proteins - deficiency; Dopamine Plasma Membrane Transport Proteins - physiology; Dopaminergic Neurons - metabolism; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Motor Activity - physiology; Receptors, Dopamine - deficiency; Receptors, Dopamine - physiology; Receptors, Glutamate - deficiency; Receptors, Glutamate - physiology; Recurrence; Ventral Tegmental Area - metabolism; alcohol; relapse; dopamine; glutamate; addiction
• ISSN: 0270-6474; 1529-2401
• DOI: 10.1523/jneurosci.2970-15.2015

Glutamatergic input within the mesolimbic dopamine (DA) pathway plays a critical role in the development of addictive behavior. Although this is well established for some drugs of abuse, it is not known whether glutamate receptors within the mesolimbic system are involved in mediating the addictive properties of chronic alcohol use. Here we evaluated the contribution of mesolimbic NMDARs and AMPARs in mediating alcohol-seeking responses induced by environmental stimuli and relapse behavior using four inducible mutant mouse lines lacking the glutamate receptor genes Grin1 or Gria1 in either DA transporter (DAT) or D1R-expressing neurons. We first demonstrate the lack of GluN1 or GluA1 in either DAT- or D1R-expressing neurons in our mutant mouse lines by colocalization studies. We then show that GluN1 and GluA1 receptor subunits within these neuronal subpopulations mediate the alcohol deprivation effect, while having no impact on context- plus cue-induced reinstatement of alcohol-seeking behavior. We further validated these results pharmacologically by demonstrating similar reductions in the alcohol deprivation effect after infusion of the NMDAR antagonist memantine into the nucleus accumbens and ventral tegmental area of control mice, and a rescue of the mutant phenotype via pharmacological potentiation of AMPAR activity using aniracetam. In conclusion, dopamine neurons as well as D1R-expressing medium spiny neurons and their glutamatergic inputs via NMDARs and AMPARs act in concert to influence relapse responses. These results provide a neuroanatomical and molecular substrate for relapse behavior and emphasize the importance of glutamatergic drugs in modulating relapse behavior.
Here we provide genetic and pharmacological evidence that glutamate receptors within the mesolimbic dopamine system play an essential role in alcohol relapse. Using various inducible and site-specific transgenic mouse models and pharmacological validation experiments, we show that critical subunits of NMDARs and AMPARs expressed either in dopamine neurons or in dopamine receptor D1-containing neurons play an important role in the alcohol deprivation effect (the increase in alcohol intake after a period of abstinence) while having no impact on context- plus cue-induced reinstatement of alcohol-seeking responses. Medications targeting glutamatergic neurotransmission by selective inactivation of these glutamate receptors might have therapeutic efficacy.